Synthesis of N- (4-fluorobenzyl)-N-(l-methylpiperidin-4-y l)-N'-(4- (2-methylpropyloxy)phenylmethyl)carba mide and its tartrate salt and crystalline forms

Details for Australian Patent Application No. 2008254238 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Thygesen, Mikkel Boas; Tolf, BoRagmar; Schlienger, Nathalie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008254238

PCT Pub. Number WO2008/144326

Priority 11/749,115 15.05.07 US

Filing date 13 May 2008

Wipo publication date 27 November 2008

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/144326 Priority application(s): WO2008/144326

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254249-Apparatus and methods for controlling spacing of conveyed objects

2008254237-Exlusive pairing technique for bluetooth (TM) compliant medical devices